Bottom line
DLHCX vs FHLC: the short answer
DLHCX (Nomura Healthcare Fund) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 108 for DLHCX, so beyond the top names it adds exposure DLHCX doesn't have.
FHLC is cheaper at 0.084% vs 1.96% — a difference of $188 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +6.7% for DLHCX (reporting dates differ).
Updated Nov 19, 2026
DLHCX vs FHLC side by side
| DLHCX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Voya | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.96% | 0.084% |
| Annual cost per $10k | $196 | $8.4 |
| 10-yr cost on $10k (prospectus) | $2,334 | $108 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +20.2% | +2.6% |
| 5-yr return (annualized) | +6.7% | +7.2% |
| 10-yr return (annualized) | +9.3% | +8.8% |
| Best quarter | — | +16.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $750.2M | $3.3B |
| Number of holdings | 108 | 337 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2025 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of DLHCX's top 25 holdings also appear in FHLC's top 25.
| Holding | DLHCX | FHLC |
|---|---|---|
| Abbvie Inc | 4.19% | 6.42% |
| Eli Lilly & Company | 4.16% | 13.35% |
| Regeneron Pharmaceuticals Inc | 3.91% | 1.15% |
| Unitedhealth Group Inc | 3.88% | 5.44% |
| Pfizer Inc | 3.84% | 2.06% |
| Merck & Company Inc | 3.68% | 4.66% |
| Gilead Sciences Inc | 3.54% | 2.34% |
| Elevance Health Inc | 3.25% | 1.19% |
| Amgen Inc | 2.27% | 3.00% |
| Vertex Pharmaceuticals Inc | 1.66% | 1.76% |
| Boston Scientific Corp | 1.42% | 1.00% |
Source: SEC Form N-PORT
DLHCX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between DLHCX and FHLC?
Which is cheaper, DLHCX or FHLC?
Should I own both DLHCX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.